At a glance
What is it—and why does it matter?
An introduction is not yet available. The findings below address specific research questions, not a complete account of this peptide.
This published profile is a reference in progress. Findings retain their source context; missing topics are marked below.
What is it?
A molecule, not a product name.
Identity
Palmitoyl pentapeptide-4 is identified in this source by the common cosmetic name Matrixyl.
- Source records
- 1
- Independent studies
- 1
Evidence boundary: Applies only to the source-defined population, formulation, dose, and assessment period.
Exact passages, locators, and provenance
- supports · Source-backed record
“Cosmetic peptides, such as palmitoyl pentapeptide-4 (Matrixyl)”
Synergistic Effects of Injectable Platelet-Rich Fibrin and Bioactive Peptides on Dermal Fibroblast Viability and Extracellular Matrix Gene Expression: An In Vitro Study. · Abstract
pubmed:40871567:7d94d93296d6:7d94d93296d6
How does it work?
Target, response, and disposition.
This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.
What has been studied?
What the evidence says.
This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.
Risks and interactions
Risks, organized for scanning.
This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.
Products and regulatory status
Same ingredient. Different records.
This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.
Administration context
The practical clinical context.
This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.
Research status + gaps
What still needs better answers?
- No publishable claim yet for: administration, contraindication, effect, interaction, mechanism, regulatory, safety
- 7 compiled claim(s) withheld by automated assurance: assurance_score_below_0.58 (5), assurance_score_below_0.72 (1), current_regulatory_source_required (1), extraction_ambiguity (6), high_risk_requires_regulatory_or_two_independent_sources (2), no_direct_support (6)
- A source-backed introductory overview is not yet available.
These are the limits of this profile, not an exhaustive list of scientific uncertainties.
References + discovery
Open the records yourself.
- Synergistic Effects of Injectable Platelet-Rich Fibrin and Bioactive Peptides on Dermal Fibroblast Viability and Extracellular Matrix Gene Expression: An In Vitro Study. ↗
pubmed · published 2025-08-19 · retrieved 2026-08-28T12:35:21Z
Publication history and provenance
Version 1 · Automated assessment · 2026-08-28T12:35:21Z
9cff76531e20c0d9a25116e4a900f88171440e2cc8925d8db57558f68f0bf287